Ketamine is a prescriptible treatment for treatment-resistant depression (TRD) in the USA and Israel, with many other countries implementing this treatment, according to Mathai et al. (2020).

Authors

• Person: Not available Organization: Springer
  Effects of psychedelics on neurogenesis and broader neuroplasticity

Sources

• Effects of psychedelics on neurogenesis and broader neuroplasticity link.springer.com Springer via serper

Referenced by nodes (4)

• ketamine concept
• treatment-resistant depression concept
• U.S. location
• Israel location